Evidence map›Paper›PMID 37968959›Full record

ArticleProblemy endokrinologii2023

[Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia].

E V Shlyakhto, G T Sukhikh, V N Serov, I I Dedov, G P Arutyunov, I A Suchkov, Ya A Orlova, E N Andreeva, S V Yureneva, I S Yavelov and 9 more

Open access · diamondAbstract readEnglish AbstractConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Problemy endokrinologii, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 2 countries.

E V ShlyakhtoNational Medical Research Center named after V.A. Almazov.
G T SukhikhNational Medical Research Center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov.
V N SerovNational Medical Research Center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov.
I I DedovEndocrinology Research Center.
G P ArutyunovRussian National Research Medical University named after N.I. Pirogov.
I A SuchkovRyazan State Medical University I.P. Pavlova.
Ya A OrlovaMedical Research and Educational Center of Moscow State University named after M.V. Lomonosov.
E N AndreevaEndocrinology Research Center.
S V YurenevaNational Medical Research Center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov.
I S YavelovNational Medical Research Center for Therapy and Preventive Medicine.
M I YarmolinskayaResearch Institute of Obstetrics, Gynecology and Reproductology named after D.O. Otta.
S V VillevaldeNational Medical Research Center named after V.A. Almazov.
O R GrigoryanEndocrinology Research Center.
E N DudinskayaRussian Gerontological Research and Clinical Center of the Russian National Research Medical University named after N.I. Pirogov.
E A IlyukhinMedalp LLC.
N A KoziolovaPerm State Medical University named after. acad. E.A. Wagner.
I V SergienkoNational Medical Research Center of Cardiology E.I. Chazov.
A A SmetnikNational Medical Research Center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov.
N I TapilskayaResearch Institute of Obstetrics, Gynecology and Reproductology named after D.O. Otta.
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation · RUEndocrinology Research Center · RUResearch Institute of Obstetrics and Gynecology named after D.O. Ott · RUMoscow State University · TJNational Medical Research Center of Cardiology · RUPerm State Medical Academy · RUPirogov Russian National Research Medical University · RURyazan State Medical University named after Academician I.P. Pavlov · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Menopausal symptoms can disrupt the life course of women at the peak of their career and family life. Currently, the most effective treatment for these manifestations is menopausal hormone therapy (MHT). The presence of cardiovascular and metabolic diseases in itself does not exclude the possibility of prescribing MHT to relieve menopausal symptoms and improve quality of life. However, often an obstacle to the use of this type of hormonal therapy is the fear of doctors who are afraid of doing more harm to patients than good. Caution is especially important when it comes to women with underlying health conditions. Moreover, it should be recognized that there is a lack of high-quality research regarding the safety of MHT for major chronic non-infectious diseases and common comorbid conditions. The presented consensus document analyzed all currently available data obtained from clinical trials of various designs and created a set of criteria for the acceptability of prescribing MHT to women with concomitant cardiovascular and metabolic diseases. Based on the presented document, doctors of various specialties who advise women in menopause will receive an accessible algorithm that will allow them to avoid potentially dangerous situations and reasonably prescribe MHT in real practice.

Indexed as

Estrogen Replacement TherapyMetabolic DiseasesEndocrinologistsFemaleGynecologistsHormonesHumansMenopauseObstetriciansQuality of LifeHormones

Identifiers

PMID37968959
PMCPMC10680541
OpenAlexW4388658859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.